Bruker Corp (BRKR) vs peers
$57.59
Latest weekly close · Market cap $8.8B
BRKR's EV/EBITDA is 52.1x, compared with 27.6x at the middle of 8 peers.
Peer group: Life Sciences Tools & Services. Updated .
| Stock | EV/EBITDA | Own 5-year percentile |
|---|---|---|
| BRKRBruker Corp | 52.1× | 97 |
| WATWaters Corporation | 51.9× | 100 |
| CRLCharles River Laboratories | 49.0× | 100 |
| TECHBio-Techne | 32.5× | 35 |
| MTDMettler Toledo | 28.5× | 70 |
| AAgilent Technologies | 26.6× | 89 |
| TMOThermo Fisher Scientific | 26.0× | 99 |
| DHRDanaher Corporation | 24.0× | 57 |
| IQVIQVIA | 17.9× | 69 |
| Peer median | 27.6× |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
EV/EBITDA divides enterprise value (market value plus debt, minus cash) by EBITDA over the last twelve months. The peer median leaves out BRKR and stocks without a reading.
Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its EV/EBITDA is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.
Different growth rates, margins and financial risks can explain different multiples. Stocks without positive EBITDA have no reading.
BRKR versus the peer median
+89%
- BRKR
- 52.1×
- Peer median
- 27.6×
- Own 5-year median
- 21.1×